Synapse - Craig Moskowitz

Search Within

Craig Moskowitz

Results (407)

Clinical experience with intravenous and oral formulations of the novel histone deacetylase inhibitor suberoylanilide hydroxamic acid in patients with advanced hematologic malignancies

Journal Article

O'Connor, O. A.; Heaney, M. L.; Schwartz, L.; Richardson, S.; Willim, R.; Macgregor-Cortelli, B.; Curly, T.; Moskowitz, C.; Portlock, C.; Horwitz, S.; more...
Journal of Clinical Oncology (2006)

Fulltext@MSK | Save

Pretreatment prognostic factors and outcome in patients with relapsed or primary-refractory diffuse large B-cell lymphoma treated with second-line chemotherapy and autologous stem cell transplantation

Journal Article

Moskowitz, C. H.
Annals of Oncology (2006)

Fulltext@MSK | Save

Is it time to stop treating subsets of DLBCL with R-CHOP?

Journal Article

Moskowitz, C.
Blood (2006)

Fulltext@MSK | Save

Surveillance imaging during remission identifies a group of patients with more favorable aggressive NHL at time of relapse: A retrospective analysis of a uniformly-treated patient population

Journal Article

Liedtke, M.; Hamlin, P. A.; Moskowitz, C. H.; Zelenetz, A. D.
Annals of Oncology (2006)

Fulltext@MSK | Save

Autologous transplantation for relapsed or primary refractory peripheral T-cell lymphoma

Journal Article

Kewalramani, T.; Zelenetz, A. D.; Teruya-Feldstein, J.; Hamlin, P.; Yahalom, J.; Horwitz, S.; Nimer, S. D.; Moskowitz, C. H.
British Journal of Haematology (2006)

Fulltext@MSK | Save

Targeting the proteasome pathway with bortezomib in patients with mantle cell (MCL) and follicular lymphoma (FL) produces prolonged progression free survival among responding patients: Results of a multicenter phase II experience

Meeting Abstract

O'connor, O.; Wright, J.; Moskowitz, C.; Straus, D.; Portlock, C.; Hamlin, P.; Neylon, E.; Evans, A.; Winter, J.; Gordon, L.; more...
Annals of Oncology (2005)

Fulltext@MSK | Save

Targeting the microtubule apparatus in indolent and mantle cell lymphoma with the novel epothilone anlog BMS 247550 induces major and durable remissions in very drug resistant disease

Meeting Abstract

O'connor, O.; Straus, D.; Moskowitz, C.; Hamlin, P.; Portlock, C.; Gerecitano, J.; Neylon, E.; Colevas, D.; Zelenetz, A.
Journal of Clinical Oncology (2005)

Fulltext@MSK | Save

Pralatrexate (10-propargyl-10-deazaaminopterin (PRX)), a novel antifolate, effects durable complete remissions (CR) in patients with a diversity of drug resistant T-cell lymphomas with minimal toxicity

Meeting Abstract

O'connor, O.; Hamlin, P. A.; Neylon, E.; Moskowitz, C.; Portlock, C. S.; Straus, D. J.; Noy, A.; Cortelli, B.; Zelenetz, A. D.; Fleisher, M.; more...
Blood (2005)

Fulltext@MSK | Save

Second-line therapy with ICE followed by high dose therapy and autologous stem cell transplantation for relapsed/refractory peripheral T-Cell lymphomas: Minimal benefit when analyzed by intent to treat

Meeting Abstract

Horwitz, S.; Moskowitz, C.; Kewalramani, T.; Hamlin, P.; Straus, D.; O'connor, O.; Noy, A.; Portlock, C.; Nimer, S.; Palomba, M. L.; more...
Blood (2005)

Fulltext@MSK | Save

Early safety and efficacy analysis of a phase II study of sequential R-CHOP and Yttrium-90 ibritumomab tiuxetan (Zevalin((R))) for elderly high risk patients with untreated DLBCL

Meeting Abstract

Hamlin, P. A.; Moskowitz, C. H.; Wegner, B. C.; Portlock, C. S.; Straus, D. J.; Noy, A.; Dumitrescu, O.; Palomba, M. L.; Horwitz, S. M.; O'Connor, O. A.; more...
Blood (2005)

Fulltext@MSK | Save